about
Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recoverySocial factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data.Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment.Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis.Barriers to sustainable tuberculosis control in the Russian Federation health system.Health-systems efficiency in the Russian Federation: tuberculosis control.Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom.Health system frailties in tuberculosis service provision in Russia: an analysis through the lens of formal nutritional support.Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US.Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis.Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions.Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis.Mental health care reforms in Europe: Rehabilitation and social inclusion of people with mental illness in Russia.Cost-effectiveness of stroke unit care followed by early supported discharge.Health system factors impacting on delivery of mental health services in Russia: multi-methods study.Costs and outcomes of tuberculosis control in the Russian Federation: retrospective cohort analysisCost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment ScenariosHigh levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX projectA framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative exampleUtilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension
P50
Q24657995-DB0A4FCE-232C-42A9-BC66-B13B81265AC9Q33225280-315B5B81-D19A-49AF-A5AD-D183889A24CAQ35557173-4C2C242D-BBCA-4A99-A67C-DA3D60368211Q35885176-0595F780-CE6B-4F0D-9A43-6BCDB22AC1EFQ37057394-93DDF5C4-6334-4121-9501-287B8DA5F0CDQ37061425-AD664DA5-797F-4A7C-AC5C-696747EAF354Q37470650-F5735D33-952D-465E-8C0F-41DE8EABAE11Q38950101-3544F5C0-51D7-4508-A25B-CBD8E62DB6AAQ39586526-9A53AFAD-47B8-4F4D-95CE-D37B1E75B565Q42660740-DAACCCE7-B24D-4464-B212-14EE7B95C8C4Q43631113-9D90000D-1FAE-4396-ADC3-A2BF8241B688Q44454238-1B3DA11E-842D-4E93-9D7B-2540EB50A70EQ48225861-1A836C01-F5CD-4697-8AF9-A988CB96AE63Q48827750-1AF3DE5B-20E0-4DED-88B0-C3362502B287Q51921419-99054CA6-F5C1-4053-B947-6FA4D5D46BFAQ58863492-E7D42D8C-96B7-47FF-946B-0F9942A966F9Q62381846-2F9DE8C4-2F3D-432A-929A-2BA0A151311FQ62493959-9F4AA295-712B-455F-A1A2-002DF597C626Q80567042-1E33183E-5FCB-4929-B354-DCCCC1379FE8Q91672464-87183F74-C24E-4AC3-B8DE-9C5557F2BE9C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yevgeniy Samyshkin
@ast
Yevgeniy Samyshkin
@en
Yevgeniy Samyshkin
@es
Yevgeniy Samyshkin
@nl
type
label
Yevgeniy Samyshkin
@ast
Yevgeniy Samyshkin
@en
Yevgeniy Samyshkin
@es
Yevgeniy Samyshkin
@nl
prefLabel
Yevgeniy Samyshkin
@ast
Yevgeniy Samyshkin
@en
Yevgeniy Samyshkin
@es
Yevgeniy Samyshkin
@nl
P108
P106
P31
P496
0000-0003-3561-5585